HDAC7

Across TCGA pan-cancer cohorts, HDAC7 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated HDAC7 data layer compared with 24 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher HDAC7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated HDAC7 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KIRC, KICH, and PRAD are the cancer types where HDAC7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.181	0.805	.002	21	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
SKCM	OS	Median	III,IV	1.000	0.690	.042	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

HDAC7–KIRC (OS)

Open the KIRC breakdown →